Hydrochloric Acid

Hydrochloric Acid

SCHEMBL272684

CCCC[Sn].Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2349731 1.00
Hydrochloric Acid SCHEMBL135075 1.00
Hydrochloric Acid SCHEMBL333348 0.96
Hydrochloric Acid SCHEMBL10870724 0.96 TSHR (0.43)
SCHEMBL29761 0.96
SCHEMBL672984 0.96
SCHEMBL11127109 0.96 TSHR (0.50)
SCHEMBL10482149 0.92
SCHEMBL6372546 0.92
SCHEMBL1127197 0.92

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 312 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119505655-A Extinction powder coating composition and preparation method and application thereof 擎天材料科技有限公司 2025-02-25 CN claimed
CN-119391362-A High-temperature-resistant single-component silicone adhesive and preparation method thereof 佛山市科菱斯科技有限公司 2025-02-07 CN claimed
CN-116903927-A Preparation method of composite butyl tin mercaptide 云南锡业锡化工材料有限责任公司 2023-10-20 CN claimed
CN-116169361-A Application of polysubstituted cyclic ether compound as lithium ion battery electrolyte solvent 合肥工业大学 2023-05-26 CN claimed
CN-114316232-B Polyester resin for high-hardness high-transparency powder coating and preparation method thereof 广东腐蚀科学与技术创新研究院 2023-04-14 CN claimed
CN-109562982-B Glass container having ink-jet printed image and method of making same 安海斯-布希英博股份有限公司 2023-02-21 CN claimed
CN-112062942-B Ultralow temperature curing polyester resin and preparation method and application thereof 擎天材料科技有限公司 2022-11-08 CN claimed
CN-109562983-B Glass container having ink-jet printed image and method of making same 安海斯-布希英博股份有限公司 2022-08-16 CN claimed
CN-114437475-A Preparation method of reverse ester tin stabilizer 泰安市蓝天助剂有限公司 2022-05-06 CN claimed
CN-114316232-A Polyester resin for high-hardness high-transparency powder coating and preparation method thereof 广东腐蚀科学与技术创新研究院 2022-04-12 CN claimed
US-20050283011-A1 Process for the production of fatty acid amides MALAYSIAN PALM OIL BOARD (MY) 2005-12-22 US claimed
WO-2005073428-A1 METHOD OF DEPOSITING FILM STACKS ON A SUBSTRATE ARKEMA INC. (US) 2005-08-11 WO claimed
EP-0782566-A4 COMPOSITIONS CONTAINING PENTAERYTHRITOL TETRAESTERS AND PROCESS FOR PRODUCTION THEREOF CK WITCO CORP (US) 2000-04-26 EP claimed
EP-0782566-A1 COMPOSITIONS CONTAINING PENTAERYTHRITOL TETRAESTERS AND PROCESS FOR PRODUCTION THEREOF WITCO CORPORATION (US) 1997-07-09 EP claimed
WO-1997003954-A1 COMPOSITIONS CONTAINING PENTAERYTHRITOL TETRAESTERS AND PROCESS FOR PRODUCTION THEREOF WITCO CORPORATION (US) 1997-02-06 WO claimed
EP-0418075-B1 Process for removing tin compounds from exhaust gases ATOCHEM NORTH AMERICA (US) 1995-06-21 EP claimed
EP-0418075-A1 Process for removing tin compounds from exhaust gases ELF ATOCHEM NORTH AMERICA, INC. (US) 1991-03-20 EP claimed
EP-0411754-A2 Medicament for the inhibition of interleukin-1 or tumor necrosis factor production by monocytes and/or macrophages SMITHKLINE BEECHAM CORPORATION (US) 1991-02-06 EP claimed
WO-1991000092-A1 INHIBITION OF INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR PRODUCTION BY MONOCYTES AND/OR MACROPHAGES SMITHKLINE BEECHAM CORPORATION (US) 1991-01-10 WO claimed
EP-0364204-A1 Pyrrolo[1,2-a]imidazole and imidazo[1,2-a]pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors SMITHKLINE BEECHAM CORPORATION (US) 1990-04-18 EP claimed